Latest news

September 1, 2022

PRISM Biolab Wins Biotech Company of the Year Award of Informa Pharma Intelligence Award 2022

We are pleased to announce that we have won the Biotech company of the year in the Private category of...
Read More
1 2 3 12

About
PRISM BIOLAB

MISSION:
PRISM BioLab is committed to maximizing the potential of its PepMetics® Technology, transforming the “undruggable” to “druggable” with the aim of finding cures for the incurable.

PRISM BioLab is a biotechnology company with PepMetics Technology, a proprietary drug discovery platform. PepMetics Molecules are designed to mimic α-helix or β-turn peptides using unique, stable scaffolds.

PepMetics
Technology

We synthesize like a small molecule, but our PepMetic Molecules act like peptides.

Peptide
MIMETICS

“PepMetics”®
LIBRARY

PRISM’s PepMetics Real Library includes 20,000+ compounds covering various amino acid sequences for screening. The PepMetics Library is used to generate hits for difficult targets.